Oxford Nanopore Technologies sign Non-Exclusive licensing agreement Genetics Research

▴ Oxford Nanopore Technologies sign Non-Exclusive licensing agreement Genetics Research
Oxford Nanopore Technologies Sign Non-Exclusive Licensing Agreement for Genetics Research’s Patented DNA Negative Enrichment Technology Platform

Genetics Research, LLC (“GR”), a privately-held company developing a portfolio of novel and proprietary CRISPR-associated technologies for targeted DNA enrichment, announced today that it has licensed certain of its patents relating to this technology to Oxford Nanopore Technologies, Ltd. (“Oxford Nanopore”) based in Oxford, United Kingdom. This license enables Oxford Nanopore to use GR patents to enhance certain offerings on its proprietary nanopore DNA/RNA sequencing platform. Terms of the non-exclusive license agreement were not disclosed.

“We are delighted to have signed this agreement with Oxford Nanopore,” said Anthony P. Shuber, President and COO of GR. “This is one part of GR’s patent portfolio, which represents a completely new approach to targeting long DNA fragments for sequence-specific enrichment. Enriching sequence-specific long DNA is complementary to sequencing platforms with the capability to analyze long fragments, and we are excited that Oxford Nanopore will be integrating this method into certain workflows on its sequencing technology.”

“GR’s novel negative enrichment approach has exciting potential synergy with Oxford Nanopore’s platform,” commented Dr Gordon Sanghera, CEO of Oxford Nanopore. “Nanopore sequencing enables users to sequence native long fragments of nucleic acids, capturing multiple variants including complex structural variation and methylation in the same experiment. Delivering targeted approaches for these analyses allows users to focus on specific genomic regions that might be of interest, and to multiplex multiple samples in a single run. This offers users a roadmap to exploiting these novel markers in clinical research across large sample cohorts. Partnering with innovators like GR is important as we introduce new ways of performing rapid, near-sample targeted sequencing to the market.”

GR’s novel and proprietary CRISPR-based enrichment platform provide multiple opportunities to enhance the field of genomic analysis. In addition to its long DNA technologies, GR has developed next-generation targeted enrichment technologies that complement PCR and hybrid capture when applied to both long and short DNA fragments. These technologies have applications across both the life sciences and diagnostics spaces, including sequence-specific multiplex analyses in FFPE, and liquid biopsies.

Genetics Research develops innovative and proprietary technologies for the development of products supporting genomic analysis in research, diagnostics, and therapeutics. Oxford Nanopore was spun out of the University of Oxford and has since developed and brought to market a new generation of tools for biological analysis.

Tags : #OxfordNanoporeTechnologies #GeneticsResearch #NonExclusiveLicensingAgreement #LatestPharmanewsUpdatesSep23 #DNANegativeEnrichmentTechnology #DNATechnologies

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Kaya Expands in Ludhiana with its 76th Clinic, Elevating Skincare with Advanced Wellness Solutions October 09, 2024
Dr Raj Nagarkar Becomes India’s 1st Oncologist on Cambridge Medical Robotics’ Advisory BoardOctober 09, 2024
Workplace Stress and Burnout Rate Reaching Critical Levels for Indian Employees, Warn ExpertsOctober 09, 2024
Are We Really Living Longer? The Surprising Reality of Life Expectancy TodayOctober 09, 2024
Could Your Irregular Heartbeat Be Reversible? How New Research is Redefining Atrial Fibrillation CareOctober 09, 2024
Defying the Odds: The Innovative Treatment Prolonging Life in Advanced Breast CancerOctober 09, 2024
Medanta Doctors Recognised in Stanford University's Global Rankings of Top 2% ScientistsOctober 09, 2024
Vector-Borne Diseases in India: 2024 OverviewOctober 09, 2024
What Makes The Mind Hear Voices: The Truth Behind Hearing Voices in SchizophreniaOctober 08, 2024
Preventing Pregnancy Complications: Why a Healthy Weight Before Conception MattersOctober 08, 2024
Are Your Favorite Beverages Putting You at Risk of Stroke? Here’s What the Latest Research SaysOctober 08, 2024
Sharp Sight Eye Hospitals Emphasizes Importance of Regular Eye Checkups with New Campaign Featuring Shishir SharmaOctober 08, 2024
Microplastics in Bloodstream: The Hidden Link to Cardiovascular and Neurological DisordersOctober 08, 2024
India Joins International Medical Device Regulators Forum: A Leap Toward Global Health CollaborationOctober 05, 2024
The Science of Overeating: Why You Can’t Stop at Just One BiteOctober 05, 2024
The Toxic Truth: How Alcohol Fuels Six Deadly CancersOctober 05, 2024
Lenacapavir: India’s Pharmaceutical Giants to Produce a Twice-a-Year Pill Poised to Rewrite HIV PreventionOctober 04, 2024
Can Ending Smoking by 2050 Really Save 1.2 Million Lives? New Lancet Study RevealsOctober 04, 2024
Colon Cancer Crisis: Why It’s Attacking Younger GenerationsOctober 04, 2024
Eye Health Program for Low-Income Residents Launched in Hingoli, MaharashtraOctober 04, 2024